Regarding pre-stroke oral anticoagulant use undergoing reperfusion therapy, frequency of taking warfarin, and NOAC were 12.1%, 4.0% on t-PA, 25.0%, 3.1% for endovascular therapy, and 15.6%, 3.0% on combined therapy (Supplementary Figure 3). Here, PLAT is linked to Stroke.